Melanoma: open trials in Australia

49 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT06060613
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Obsidian Therapeutics, Inc.
Melanoma Institute of Australia, Wollstonecraft
Registry updated 2026-11-03
NCT06305962
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Trial Treatment · Early phase 1 · Radiopharm Theranostics, Ltd
Cancer Research SA (CRSA), Adelaide · Gosford Hospital, Gosford · Nepean Hospital, Kingswood · GenesisCare Murdoch, Murdoch · Gold Coast University Hospital, Southport · Wollongong Hospital, Wollongong
Registry updated 2026-11-02
NCT06953089
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 2 · DualityBio Inc.
AUS05-0, Adelaide · AUS06-0, Benowa · AUS04-0, Birtinya · AUS07-0, North Sydney
Registry updated 2026-10-29
NCT07072728
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Trial Treatment · Phase 2 · Psyence Australia Pty Ltd
Mind Medicine Australia Clinic, Abbotsford · Empax Centre, Leederville · Neurocentrix, Melbourne · Ramsay Northside Clinic, Melbourne · Paratus Clinical Research Melbourne, Northcote
Registry updated 2026-10-29
NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1 · MacroGenics
ICON Cancer Centre Wesley, Auchenflower · Austin Health- Olivia Newton John Cancer Center, Heidelberg · Icon Cancer Centre Kurralta Park, Kurralta Park
Registry updated 2026-10-28
NCT07751042
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Trial Treatment · Phase 1/2 · Strand Therapeutics Inc.
Melanoma Institute Australia, Wollstonecraft
Registry updated 2026-10-27
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Chris O'Brien Lifehouse, Camperdown · Icon Cancer Centre Chermside, Chermside · Monash Medical Centre Clayton, Clayton · Icon Cancer Centre Hobart, Hobart · Icon Cancer Centre Townsville, Hyde Park
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Blacktown Hospital, Blacktown · St Vincent'S Hospital Sydney, Mount Kuring-Gai · GenesisCare -North Shore Oncology, St Leonards · St. John of God Subiaco Hospital, Subiaco · Princess Alexandra Hospital, Woolloongabba
Registry updated 2026-10-26
NCT07565285
The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma
Trial Treatment · Phase 2 · Primmune Therapeutics, Inc.
Cairns and Hinterland Hospital and Health Service, Cairns · Gallipoli Medical Research, Greenslopes · Peter MacCallum Cancer Centre, Melbourne · Sir Charles Gairdner Hospital, Nedlands · One Clinical Research Pty Ltd, Nedlands · Calvary Mater Newcastle, Waratah · Princess Alexandra Hospital, Woolloongabba
Registry updated 2026-10-23
NCT05914116
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · DualityBio Inc.
Birtinya · Blacktown · Brisbane · Camperdown · Concord · Gold Coast · Nedlands · Nedlands · New Lambton Heights · Sydney · Sydney · Sydney · Waratah
Registry updated 2026-10-21
NCT07339176
Intratumoral N17350 in Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Onchilles Pharma Inc
Peter MacCallum Cancer Centre (PMCC), Melbourne · Calvary Mater Hospital, Newcastle · Westmead Hospital, Westmead
Registry updated 2026-10-21
NCT06163820
Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases
Trial Treatment · Phase 1/2 · Melanoma and Skin Cancer Trials Limited
Alfred Health, Melbourne
Registry updated 2026-10-13
NCT07070232
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Trial Treatment · Phase 1/2 · BioNTech SE
Cancer Research SA, Adelaide · Blacktown Hospital, Blacktown · St Vincent's Hospital Sydney, Darlinghurst · Peninsula and South Eastern Haematology & Oncology Group, Frankston · Austin Health, Heidelberg · The Alfred Hospital, Melbourne · One Clinical Research Pty Ltd, Nedlands · Tasman Oncology Research Ltd, Southport · Melanoma Institute Australia, Wollstonecraft
Registry updated 2026-10-09
NCT03340129
Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
Trial Treatment · Phase 2 · Melanoma Institute Australia
Royal Adelaide Hospital, Adelaide · Peter MacCallum Cancer Centre, East Melbourne · Alfred Hospital, Melbourne · Sir Charles Gairdner Hosptial, Perth · Westmead Hospital, Sydney · Calvary Mater NewcastleHospital, Waratah · Melanoma Institute Australia, Wollstonecraft · Princess Alexandra Hospital, Woolloongabba
Registry updated 2026-10-08
NCT07115043
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · AstraZeneca
East Melbourne
Registry updated 2026-10-08
NCT06536257
Personalised Immunotherapy Platform
Research · Melanoma Institute Australia
Melanoma Institute Australia, Sydney · Westmead Hospital, Sydney · Chris O'Brien Lifehouse, Sydney
Registry updated 2026-10-07
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Southern Adelaide Local Health Network Incorporated Flinders Medical Centre, Bedford Park · Eastern Health, Box Hill · Icon Cancer Centre Chermside, Chermside · Peninsula and South Eastern Haematology and Oncology Group, Frankston · Cancer Care Wollongong, Wollongong
Registry updated 2026-10-06
NCT06961006
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Blacktown Hospital (Site 2001), Blacktown · One Clinical Research (Site 2002), Nedlands · Melanoma Institute Australia (Site 2000), Wollstonecraft
Registry updated 2026-09-28
NCT05727904
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Trial Treatment · Phase 3 · Iovance Biotherapeutics, Inc.
Flinders Medical Centre, Bedford Park · Greenslopes Private Hospital, Greenslopes · Peter MacCallum Cancer Centre, Melbourne · Fiona Stanley Hospital, Murdoch · Westmead Hospital, Westmead
Registry updated 2026-09-24
NCT05267626
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Trial Treatment · Phase 1/2 · Aulos Bioscience, Inc.
Southern Oncology Clinical Research Unit, Bedford Park · Monash Health, Clayton · Peninsula & South Eastern Haematology and Oncology Group, Frankston · Austin Health, Heidelberg · The Alfred Hospital, Melbourne · Southside Cancer Care Centre, Miranda · Sunshine Hospital, Saint Albans
Registry updated 2026-09-18
NCT06585410
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
The Skin Hospital, Darlinghurst · Fremantle Dermatology, Fremantle · Dermatology Institute of Victoria (DIV), South Yarra · Westmead Hospital, Westmead · Princess Alexandra Hospital, Woolloongabba
Registry updated 2026-09-16
NCT07341737
SL-28 for Advanced Solid Tumours
Trial Treatment · Phase 1/2 · Second Life Therapeutics
The Southern Oncology Clinical Research Unit (SOCRU), Adelaide · John Flynn Private Hospital, Gold Coast · Liverpool Hospital, Sydney
Registry updated 2026-09-15
NCT04913285
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Trial Treatment · Phase 1 · Pierre Fabre Medicament
Austin Health, Heidelberg · Linear Clinical Research, Perth · Tasman Health Care, Southport · Calvary Mater Hospital Newcastle, Waratah · Melanoma Institute Australia, Wollstonecraft
Registry updated 2026-09-02
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Blacktown Hospital, Blacktown · Princess Alexandra Hospital, Brisbane · Liverpool Hospital, Liverpool · Cabrini Hospital - Malvern, Malvern · St Vincent's Hospital, Melbourne · One Clinical Research, Nedlands
Registry updated 2026-08-17
NCT06910657
IDOV-Immune for Advanced Solid Tumors
Trial Treatment · Phase 1 · ViroMissile, Inc.
The Alfred Hospital, Melbourne · Westmead Hospital, Westmead
Registry updated 2026-08-05

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error